>
网站首页期刊介绍通知公告编 委 会投稿须知电子期刊广告合作联系我们
最新消息:
转录因子Ets-1在2型糖尿病肾病中的表达及其意义
作者:沈京群1 2  刘殿阁1 2  陈涵枝2  丁弘2  汪湜2  周建东2 
单位:1. 哈尔滨医科大学附属第一医院 肾内科,黑龙江 哈尔滨 150001;
2. 东南大学附属中大医院 肾内科,江苏 南京 210009
关键词:Ets-1 基质金属蛋白酶-2 基质金属蛋白酶-2组织抑制剂 α-平滑肌肌动蛋白 波形蛋白 胶原Ⅳ 糖尿病肾病 免疫组化 
分类号:R587.2
出版年·卷·期(页码):2012·31·第四期(419-424)
摘要:

目的:观察转录因子Ets-1、基质金属蛋白酶-2 (MMP-2)、基质金属蛋白酶-2组织抑制剂(TIMP-2)、α-平滑肌肌动蛋白(α-SMA)、波形蛋白(vimentin)和Ⅳ型胶原(Col Ⅳ)在2型糖尿病肾病(DN)中的表达及探讨其意义。方法:糖尿病肾病组25例;轻微病变性肾病(MCD)20例设为对照组。采用免疫组织化学染色,观察各实验组肾组织内Ets-1、MMP-2、TIMP-2、α-SMA、vimentin及Col Ⅳ的表达,并行免疫双染共定位分析。结果:25例DN患者中,男15例,女10例;年龄35~67岁。对照组20例MCD患者中,男12例,女8例;年龄18~46岁。与对照组相比,DN组肾小球内Ets-1表达显著性增加(P<0.05),肾小管间质纤维化区域内Ets-1表达亦明显增加(P<0.05);DN组MMP-2在肾小球及肾小管间质内的表达显著性增加(P<0.05);TIMP-2在肾小球及肾小管间质内的表达也明显增加(P<0.05),肾小球及肾小管间质内MMP-2/TIMP-2比值却显著性降低,差异有统计学意义(P<0.05)。与对照组相比,DN组肾小球内α-SMA、vimentin及Col Ⅳ表达明显增加(P<0.05),肾小管间质内α-SMA及Col Ⅳ表达亦明显增加(P<0.05),vimentin在肾小管间质内表达则显著性增加(P<0.01)。免疫双染显示,2型DN肾组织内大多数Ets-1阳性细胞同时出现MMP-2阳性表达,而α-SMA阳性细胞同时具有Col Ⅳ阳性表达。结论:Ets-1转录因子可能通过调节MMP-2/TIMP-2系统平衡,影响ECM沉积,在2型DN基质重塑过程中起关键性作用。

Objective: Ets-1 proto-oncogene is a member of the transcriptional factor family and was identified by homology to the V-ets oncogene. It was recently demonstrated that Ets-1 protein interacts with the promoter region of the genes coding for proteinases, including matrix metalloproteinases (MMPs), suggesting that it may play an important role in the regulation of MMPs expression. The role of the Ets-1 proto-oncogene in diabetic nephropathy (DN), where extracellular matrix (ECM) accumulation is observed, remains undefined. To elucidate the role of Ets-1 in DN,we studied the expression pattern of Ets-1,Matrix metaloproteinase-2 (MMP-2), Tissue Inhibitors of Metalloproteinase-2 (TIMP-2), α-smooth muscle action (α-SMA) and type Ⅳ collagen (Col Ⅳ) in matrix remodeling in Type 2 DN. Methods: 25 cases of renal biopsy sections diagnosed as DN were selected. Type 2 diabetes was defined according to Standards of Medical Care in diabetes. 2007/ADA. Meanwhile, 20 cases of renal biopsy specimens diagnosed as minor glomerular abnormalities (minimal change disease, MCD) were simultaneously studied as controls. Pathological classifications were made according to the WHO criteria of 1982 for renal pathology or the modified WHO criteria of 1995. Histopathological findings were identified under light microscopy. Using immunohistochemistry and double immunostaining, we investigated the expression of Ets-1, MMP-2, TIMP-2, α-SMA, vimentin and collagen type Ⅳ(Col Ⅳ)in type 2 DN. The experimental data was statistically analyzed and statistical significance was achieved at corrected P<0.05.Results: 25 DN cases (male 15,female 10) between the ages of 35 and 67 years were observed. 20 MCD patients (male 12, female 8), aged l8-46 years, were noted. By immunnohistochemistry, the expression of Ets-1 in glomeruli and tubulointerstitium was significantly increased in the kidneys obtained from DN group compared with MCD groups(P<0.05). Compared to MCD patients, increased expression of MMP-2, TIMP-2, α-SMA, vimentin and Col Ⅳ in glomeruli was observed in DN patients (P<0.05). Specially, the ratio of MMP-2 and TIMP-2 in glomeruli and tubulointerstitium from 2 Type DN compared with control group (P<0.05). Meanwhile, overexpression of α-SMA and deposition of Col Ⅳ in tubulointersitium was observed in the DN patients (P<0.05), the expression of vimentin in tubulointerstitium was significantly increased (P<0.05). By double immunostaining, α-SMA positive cells were frequently found to co-express Col Ⅳ in glomemli and tubulointersitium of Type 2 DN patients. Increased expression of MMP-2 concorded with the increased expression of Ets-1 in the kidneys obtained from Type 2 DN. Conclusion: Ets-1 transcription factor may regulate the balance of MMP-2 and TIMP-2 enzyme system, and closely associated with increased deposition of ECM. Ets-1 plays a critical role in matrix remodeling in human Type 2 DN.

参考文献:

[1] KANWAR Y S,WADA J,SUN L,et al.Diabetic Nephropathy:Mechanisms of Renal Disease Progression[J].Exp Bio Med,2008,233:4-11.
[2] SUMIMOE A,MATSUZAKI A,HATTORI H,et al.Expression of matrix metalloproteinase (MMP) and tissue inhibitor of MMP (TIMP) genes in blasts of infant acute lymphoblastic leukemia with organ involvement[J].Luek Res,2007,31:1437-1440.
[3] NAKAMURA Y,ESNAULT S,MAEDA T,et al.Ets-1 regulates TNF γ induced matrix metalloproteinase-9 and tenascin expression in primary bronchial fibroblasts[J].J Immunol,2004,172:1945-1952.
[4] 陈涵枝,刘殿阁,丁弘,等. Ets-1在大鼠顺铂相关性肾病基质重塑中的作用[J].现代医学,2008,36(5):301-305.
[5] 刘殿阁,张庆娟,宫壮,等. 热休克蛋白47在大鼠糖尿病肾病中的作用[J].中华病理学杂志,2007,36(9):627-628.
[6] LIU D,RAZZAQUE M S,NAZNEEN A,et al.Role of heat shock protein 47 on tubulointerstitium in experimental radiation nephropathy[J].Pathol Int,2002,52 (5-6):340-347.
[7] LI H,CHEN B K,SHAH,et al.Socioeconomic correlates of inpatient spending for patients with type 2 diabetes mellitus in china: evidence from hangzhou[J].Exp Clin Endocrinol Diabetes,2012,120(1):35-44.
[8] BAILLAT D,LAITEM C,LEPRIVIER G,et al.Ets-1 binds cooperatively to the palindromic Ets-binding sites in the p53 promoter[J].Biochem Biophys Res Commun,2009,378:213-217.
[9] HINSBERGH V W M,KOOLWIJK P.Endothelial sprouting and angiogenesis:matrix metalloproteinases in the lead[J].Cardiovasc Res,2008,78:203-212.
[10] LEE M H,ATKINSON S,MURPHY G.Identification of the extracellular matrix (ECM) binding motifs of tissue inhibitor of metalloproteinases (TIMP)-3 and effective transfer to TIMP-1[J].J Biol Chem,2007,282(9):6887-6898.
[11] 沈京群,刘殿阁.转录因子Ets在肾脏细胞外基质重塑中的作用[J].东南大学学报:医学版,2010,29 (2):224-227.
[12] VALLEDOR A F,ESTER S T,ARPA L,et al.Selective roles of MAPKs during the macrophage response to IFN-γ[J].J Immunol,2008,180:4523-4529.
[13] MIZUI M,ISAKA Y,TAKABATAKE Y,et al.Transcription factor Ets-1 is essential for mesangial matrix remodeling[J].Kidney Int,2006,70:298-305.

服务与反馈:
文章下载】【发表评论】【查看评论】【加入收藏
提示:您还未登录,请登录!点此登录
您是第 187081 位访问者


copyright ©《东南大学学报(医学版)》编辑部
联系电话:025-87232481 83272483
电子邮件:
bjb@pub.seu.edu.cn

苏ICP备09058364